Adaptive Biotechnologies Stock (NASDAQ: ADPT) stock price, news, charts, stock research, profile.
You can purchase shares of Adaptive Biotechnologies (NASDAQ:ADPT) through any online brokerage.
Other companies in Adaptive Biotechnologies’s space includes: 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Sotera Health (NASDAQ:SHC).
Adaptive Biotechnologies has a consensus price target of $8.29.
The stock price for Adaptive Biotechnologies (NASDAQ: ADPT) is $5.72 last updated November 25, 2024 at 6:55 PM EST.
There are no upcoming dividends for Adaptive Biotechnologies.
Adaptive Biotechnologies’s Q4 earnings are confirmed for Wednesday, February 12, 2025.
There is no upcoming split for Adaptive Biotechnologies.
Adaptive Biotechnologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.